Here, we advocate the development of true causal chemoprophylactic drugs that will fully inhibit the obligate short-lived hepatic forms that precede blood infections. Such drugs will prevent ...

A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...

Vimseltinib is now an FDA-approved treatment for patients with tenosynovial giant cell tumor, based on findings from the ...

Pazopanib-associated ALT elevations have a robust, confirmed association with HFE polymorphisms, suggesting that some of these changes may be linked to regulation of hepatic iron deposition.

Acute and chronic treatment for hepatic encephalopathy acquired from Mallinckrodt Pharmaceuticals in September 2024Extended pre-clinical, ...

Given the potential for synergistic hepatotoxicity with other medications (eg, acetaminophen), alcohol9 10 and herbal supplements, the public health community should focus intense scrutiny on possible ...

Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an update ...

Hepatotoxicity is damage or injury to the liver as a result of damaging or destructive agents such as drugs or industrial chemicals which are termed hepatotoxins. This study reveals that ...

The supplement industry is booming—but so are serious health issues tied to taking these pills and powders. Here’s what ...

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

The patient was diagnosed with drug-induced acute hepatitis. His hepatic transaminase levels declined but his bilirubin levels continued to rise. He was readmitted with a hemoglobin concentration ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...